These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8303660)

  • 41. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
    Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of tissue-type plasminogen activator by retinoids in rat plasma and tissues.
    Van Bennekum AM; Emeis JJ; Kooistra T; Hendriks HF
    Am J Physiol; 1993 May; 264(5 Pt 2):R931-7. PubMed ID: 8498603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled insect-sting challenge in 55 patients: correlation between activation of plasminogen and the development of anaphylactic shock.
    van der Linden PW; Hack CE; Struyvenberg A; Roem D; Brouwer MC; de Boer JP; van der Zwan JK
    Blood; 1993 Sep; 82(6):1740-8. PubMed ID: 7691234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
    Charles MA; Morange P; Eschwège E; André P; Vague P; Juhan-Vague I
    Diabetes Care; 1998 Nov; 21(11):1967-72. PubMed ID: 9802752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
    Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
    Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon.
    Marasini B; Cugno M; Bassani C; Stanzani M; Bottasso B; Agostoni A
    Int J Microcirc Clin Exp; 1992 Nov; 11(4):375-82. PubMed ID: 1459797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
    Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of atenolol or losartan on fibrinolysis and von Willebrand factor in hypertensive patients with left ventricular hypertrophy.
    Boman K; Boman JH; Andersson J; Olofsson M; Dahlöf B
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):146-52. PubMed ID: 19825910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina.
    Gurfinkel E; Altman R; Scazziota A; Rouvier J; Mautner B
    Br Heart J; 1994 Feb; 71(2):151-5. PubMed ID: 8130023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.